1. Home
  2. WORX vs BIAF Comparison

WORX vs BIAF Comparison

Compare WORX & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

HOLD

Current Price

$0.12

Market Cap

4.3M

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.04

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WORX
BIAF
Founded
N/A
2014
Country
United States
United States
Employees
N/A
57
Industry
Services-Misc. Amusement & Recreation
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.6M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
WORX
BIAF
Price
$0.12
$1.04
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
15.7M
226.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
79.79
N/A
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.16
52 Week High
$1.37
$13.50

Technical Indicators

Market Signals
Indicator
WORX
BIAF
Relative Strength Index (RSI) 32.74 47.36
Support Level N/A $0.90
Resistance Level $0.35 $1.45
Average True Range (ATR) 0.07 0.12
MACD -0.03 0.01
Stochastic Oscillator 2.78 28.57

Price Performance

Historical Comparison
WORX
BIAF

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: